Lixisenatide
24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
Sanofi · Phase 3 · Completed · Enrollment 319
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Lixisenatide | 18.4% | n/r | n/r | n/r |
| Sitagliptin | 11.9% | n/r | n/r | n/r |
Not shown
Every selected arm is drawn.